Ken Griffin Pet Iq, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Pet Iq, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 6,800 shares of PETQ stock, worth $210,664. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,800

Previous 10,100 32.67%

Holding current value

$210,664

Previous $184,000 18.48%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$15.93 - $22.26 $4.1 Million - $5.72 Million	-257,120 Reduced 96.27%	9,959 $219,000
Q1 2024 May 15, 2024	BUY	$15.55 - $19.42 $3.99 Million - $4.99 Million	256,802 Added 2498.8%	267,079 $4.88 Million
Q4 2023 Feb 14, 2024	SELL	$17.18 - $22.38 $2.58 Million - $3.36 Million	-150,243 Reduced 93.6%	10,277 $202,000
Q3 2023 Nov 14, 2023	BUY	$15.0 - $20.71 $786,330 - $1.09 Million	52,422 Added 48.49%	160,520 $3.16 Million
Q2 2023 Aug 14, 2023	SELL	$10.84 - $15.43 $42,752 - $60,855	-3,944 Reduced 3.52%	108,098 $1.64 Million
Q1 2023 May 15, 2023	SELL	$9.32 - $12.58 $830,775 - $1.12 Million	-89,139 Reduced 44.31%	112,042 $1.28 Million
Q4 2022 Feb 14, 2023	SELL	$6.82 - $12.07 $2.48 Million - $4.4 Million	-364,180 Reduced 64.42%	201,181 $1.85 Million
Q3 2022 Nov 14, 2022	BUY	$6.9 - $18.16 $2.88 Million - $7.58 Million	417,264 Added 281.75%	565,361 $3.9 Million
Q2 2022 Aug 15, 2022	SELL	$14.09 - $25.12 $749,912 - $1.34 Million	-53,223 Reduced 26.44%	148,097 $2.49 Million
Q1 2022 May 16, 2022	BUY	$17.92 - $24.4 $1.8 Million - $2.45 Million	100,553 Added 99.79%	201,320 $4.91 Million
Q4 2021 Feb 14, 2022	BUY	$19.97 - $25.91 $1.07 Million - $1.38 Million	53,393 Added 112.71%	100,767 $2.29 Million
Q3 2021 Nov 15, 2021	SELL	$23.99 - $38.59 $2.96 Million - $4.77 Million	-123,592 Reduced 72.29%	47,374 $1.18 Million
Q2 2021 Aug 16, 2021	BUY	$34.94 - $45.35 $1.06 Million - $1.37 Million	30,274 Added 21.52%	170,966 $6.6 Million
Q1 2021 May 17, 2021	BUY	$32.6 - $37.82 $2.61 Million - $3.03 Million	80,037 Added 131.95%	140,692 $4.96 Million
Q4 2020 Feb 16, 2021	SELL	$24.99 - $38.45 $2.48 Million - $3.82 Million	-99,404 Reduced 62.1%	60,655 $2.33 Million
Q3 2020 Nov 16, 2020	BUY	$29.04 - $37.49 $3.22 Million - $4.16 Million	111,023 Added 226.41%	160,059 $5.27 Million
Q2 2020 Aug 14, 2020	SELL	$20.16 - $34.84 $370,339 - $640,010	-18,370 Reduced 27.25%	49,036 $1.71 Million
Q1 2020 May 15, 2020	SELL	$16.59 - $34.94 $674,400 - $1.42 Million	-40,651 Reduced 37.62%	67,406 $1.57 Million
Q4 2019 Feb 14, 2020	SELL	$22.24 - $27.56 $3.95 Million - $4.9 Million	-177,654 Reduced 62.18%	108,057 $2.71 Million
Q3 2019 Nov 14, 2019	BUY	$25.56 - $36.1 $7.3 Million - $10.3 Million	285,711 New	285,711 $7.79 Million

Others Institutions Holding PETQ

# of Institutions

177

Shares Held

26.5M

Call Options Held

78.8K

Put Options Held

111K

View Full List

About PetIQ, Inc.

Ticker PETQ
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,312,800
Market Cap $908M
Description
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...

More about PETQ

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account